| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.009 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |